These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3930247)

  • 1. Intravenous administration of a thrombolytic agent is the only realistic therapeutic approach in evolving myocardial infarction.
    Verstraete M
    Eur Heart J; 1985 Jul; 6(7):586-93. PubMed ID: 3930247
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic versus intracoronary thrombolytic treatment in acute myocardial infarction.
    Verstraete M
    Acta Cardiol; 1985; 40(3):263-7. PubMed ID: 3895791
    [No Abstract]   [Full Text] [Related]  

  • 3. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
    GUSTO investigators
    N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.
    GUSTO Angiographic Investigators
    N Engl J Med; 1993 Nov; 329(22):1615-22. PubMed ID: 8232430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolytic therapy for myocardial infarction: a perspective of clinical trialists. The GUSTO Investigators.
    Califf RM; Topol EJ
    Clin Cardiol; 1992 Mar; 15(3):143-4. PubMed ID: 1551260
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GUSTO (Global Utilization of Streptokinase and Tissue plasminogen activator in Occluded arteries): logic wins at last.
    Bassand JP
    Eur Heart J; 1994 Jan; 15(1):2-4. PubMed ID: 8174579
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fibrinolytic treatment of acute myocardial infarct].
    Neuhaus KL
    Fortschr Med; 1986 Aug; 104(30):578-82. PubMed ID: 3093344
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombolytic treatment in acute myocardial infarction.
    Verstraete M
    Circulation; 1990 Sep; 82(3 Suppl):II96-109. PubMed ID: 2118432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials and decisions for thrombolytic therapy in patients with acute myocardial infarction.
    Conti CR
    Clin Cardiol; 1990 May; 13(5):307-8. PubMed ID: 2112073
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombolytic therapy in acute myocardial infarction utilizing high-dose, short-term intravenous streptokinase: report of a case and review of the literature.
    Arnold WV; Kirschbaum MJ; D'Alonzo AF; Sallen MK; Dickerson WH
    J Am Osteopath Assoc; 1986 Apr; 86(4):243-7. PubMed ID: 3700159
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous versus intracoronary streptokinase for acute transmural myocardial infarction.
    Blunda M; Meister SG; Shechter JA; Pickering NJ; Wolf NM
    Cathet Cardiovasc Diagn; 1984; 10(4):319-27. PubMed ID: 6488304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolysis with tissue-type plasminogen activator in acute myocardial infarction. Potentials and pitfalls.
    Jaffe AS; Sobel BE
    JAMA; 1986 Jan; 255(2):237-9. PubMed ID: 3079842
    [No Abstract]   [Full Text] [Related]  

  • 14. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thrombolytic therapy in acute myocardial infarct].
    Rentrop P; Blanke H
    Dtsch Med Wochenschr; 1985 May; 110(22):885-9. PubMed ID: 3158507
    [No Abstract]   [Full Text] [Related]  

  • 16. The GUSTO trial: is the open-artery hypothesis proven?
    Stringer KA; Lindenfeld J
    Ann Pharmacother; 1994 Jan; 28(1):97-8. PubMed ID: 8123971
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thrombolytic therapy of acute heart infarct].
    Schwarz F; Kübler W
    Internist (Berl); 1984 Dec; 25(12):713-20. PubMed ID: 6240475
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombolysis, streptokinase, and TPA in the treatment of acute myocardial infarction.
    Mock MB; Chesebro JH
    Cardiovasc Clin; 1987; 18(1):247-57. PubMed ID: 2955892
    [No Abstract]   [Full Text] [Related]  

  • 19. Better patency with SK than with tPA?
    Peto R; Collins R
    J Am Coll Cardiol; 1999 Jan; 33(1):287-8. PubMed ID: 9935044
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombolytic therapy for myocardial infarction: the problem, the promise and the price.
    Waters DD; Wiseman A
    CMAJ; 1988 Apr; 138(7):598-601. PubMed ID: 3128395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.